Your browser is no longer supported. Please, upgrade your browser.
HOTH Hoth Therapeutics, Inc. daily Stock Chart
Hoth Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.87 Insider Own8.50% Shs Outstand10.25M Perf Week-3.10%
Market Cap33.80M Forward P/E- EPS next Y-0.47 Insider Trans-25.82% Shs Float7.58M Perf Month-12.89%
Income-8.70M PEG- EPS next Q-0.15 Inst Own0.30% Short Float4.09% Perf Quarter-14.68%
Sales- P/S- EPS this Y-69.50% Inst Trans-2.41% Short Ratio0.63 Perf Half Y-62.06%
Book/sh0.47 P/B5.32 EPS next Y21.70% ROA-205.40% Target Price- Perf Year-56.82%
Cash/sh0.36 P/C7.04 EPS next 5Y- ROE-221.40% 52W Range2.31 - 7.87 Perf YTD-59.61%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-68.23% Beta-
Dividend %- Quick Ratio9.40 Sales past 5Y- Gross Margin- 52W Low8.23% ATR0.14
Employees2 Current Ratio9.40 Sales Q/Q- Oper. Margin- RSI (14)32.81 Volatility6.17% 5.24%
OptionableNo Debt/Eq0.00 EPS Q/Q-50.50% Profit Margin- Rel Volume0.31 Prev Close2.58
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume495.33K Price2.50
Recom2.00 SMA20-6.24% SMA50-20.13% SMA200-38.20% Volume151,919 Change-3.10%
Oct-15-19Initiated The Benchmark Company Speculative Buy $10
Jun-30-20 09:08AM  
Jun-16-20 09:24AM  
Jun-15-20 08:48AM  
Jun-14-20 11:43AM  
Jun-08-20 09:08AM  
Jun-03-20 08:00AM  
May-27-20 01:50PM  
May-22-20 08:00AM  
May-21-20 09:07PM  
May-20-20 08:00AM  
May-18-20 08:00AM  
May-05-20 09:40AM  
Apr-24-20 10:08AM  
Apr-23-20 09:42AM  
Apr-22-20 08:07AM  
Apr-21-20 10:18AM  
Apr-17-20 08:00AM  
Apr-15-20 09:13AM  
Apr-09-20 08:00AM  
Apr-02-20 11:04AM  
Mar-30-20 08:48AM  
Mar-27-20 08:00AM  
Mar-25-20 10:34AM  
Mar-24-20 11:50AM  
Mar-23-20 04:52PM  
Mar-19-20 10:05AM  
Mar-09-20 09:18AM  
Feb-19-20 10:45AM  
Feb-12-20 08:48AM  
Feb-11-20 08:00AM  
Feb-04-20 01:00PM  
Jan-29-20 07:00AM  
Jan-21-20 07:00AM  
Jan-17-20 07:00AM  
Jan-15-20 07:00AM  
Jan-14-20 07:00AM  
Dec-23-19 07:00AM  
Dec-19-19 07:00AM  
Dec-17-19 11:00AM  
Dec-13-19 07:00AM  
Dec-11-19 12:30PM  
Dec-09-19 01:45PM  
Nov-26-19 01:07PM  
Nov-18-19 08:00AM  
Nov-14-19 08:00AM  
Nov-11-19 01:42PM  
Nov-06-19 08:00AM  
Oct-16-19 11:53AM  
Oct-15-19 08:00AM  
Oct-14-19 08:00AM  
Oct-08-19 08:30AM  
Sep-25-19 12:32PM  
Sep-24-19 08:00AM  
Sep-18-19 10:51AM  
Sep-16-19 02:41PM  
Sep-06-19 08:00AM  
Sep-04-19 08:00AM  
Aug-21-19 08:00AM  
Aug-01-19 02:25PM  
Jul-22-19 08:00AM  
Jul-15-19 08:00AM  
Jun-27-19 08:00AM  
Jun-13-19 08:00AM  
Jun-10-19 08:00AM  
Jun-06-19 08:00AM  
May-29-19 08:00AM  
May-14-19 08:00AM  
Apr-30-19 08:00AM  
Apr-18-19 08:00AM  
Apr-08-19 08:00AM  
Mar-19-19 08:00AM  
Mar-13-19 08:00AM  
Mar-11-19 08:00AM  
Mar-04-19 08:00AM  
Feb-25-19 08:00AM  
Feb-20-19 05:15PM  
Feb-15-19 08:00AM  
Hoth Therapeutics, Inc., a biopharmaceutical company, focuses on developing therapies for dermatological disorders. The company focuses on therapies for patients suffering from indications, including eczema, chronic wounds, psoriasis, asthma, and acne. It intends to use the BioLexa Platform to develop two topical cream products that treat eczema and reduces post-procedure infections for patients undergoing aesthetic dermatology procedures. The company has license agreements with the George Washington University; the University of Maryland Baltimore; Isoprene Pharmaceuticals, Inc.; the North Carolina State University; Zylo Therapeutics, Inc.; Chelexa BioSciences, Inc.; and the University of Cincinnati. Hoth Therapeutics, Inc. was founded in 2017 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hayes Anthony10% OwnerMay 26Sale1.25400,000500,0001,130,674May 29 04:23 PM